p62 Is a Key Regulator of Nutrient Sensing in the mTORC1 Pathway

被引:438
作者
Duran, Angeles [1 ,2 ]
Amanchy, Ramars [2 ]
Linares, Juan F. [1 ,2 ]
Joshi, Jayashree [2 ]
Abu-Baker, Shadi [2 ]
Porollo, Aleksey [2 ]
Hansen, Malene [1 ]
Moscat, Jorge [1 ,2 ]
Diaz-Meco, Maria T. [1 ,2 ]
机构
[1] Sanford Burnham Med Res Inst, La Jolla, CA 92307 USA
[2] Univ Cincinnati, Coll Med, Vontz Ctr Mol Studies, Dept Canc & Cell Biol, Cincinnati, OH 45267 USA
基金
美国国家卫生研究院;
关键词
INTERACTING PROTEIN P62; SIGNALING ADAPTER P62; GTP-BINDING PROTEINS; IMPORTANT MEDIATOR; RAG GTPASES; COMPLEX; CANCER; DEGRADATION; DOWNSTREAM; ACTIVATION;
D O I
10.1016/j.molcel.2011.06.038
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The signaling adaptor p62 is a critical mediator of important cellular functions, owing to its ability to establish interactions with various signaling intermediaries. Here, we identify raptor as an interacting partner of p62. Thus, p62 is an integral part of the mTORC1 complex and is necessary to mediate amino acid signaling for the activation of S6K1 and 4EBP1. p62 interacts in an amino acid-dependent manner with mTOR and raptor. In addition, p62 binds the Rags proteins and favors formation of the active Rag heterodimer that is further stabilized by raptor. Interestingly, p62 colocalizes with Rags at the lysosomal compartment and is required for the interaction of mTOR with Rag GTPases in vivo and for translocation of the mTORC1 complex to the lysosome, a crucial step for mTOR activation.
引用
收藏
页码:134 / 146
页数:13
相关论文
共 35 条
[1]   The atypical PKC-interacting protein p62 is an important mediator of RANK-activated osteoclastogenesis [J].
Durán, A ;
Serrano, M ;
Leitges, M ;
Flores, JM ;
Picard, S ;
Brown, JP ;
Moscat, J ;
Diaz-Meco, MT .
DEVELOPMENTAL CELL, 2004, 6 (02) :303-309
[2]   The signaling adaptor p62 is an important NF-κB mediator in tumorigenesis [J].
Duran, Angeles ;
Linares, Juan F. ;
Galvez, Anita S. ;
Wikenheiser, Kathryn ;
Flores, Juana M. ;
Diaz-Meco, Maria T. ;
Moscat, Jorge .
CANCER CELL, 2008, 13 (04) :343-354
[3]   Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E [J].
Fingar, DC ;
Salama, S ;
Tsou, C ;
Harlow, E ;
Blenis, J .
GENES & DEVELOPMENT, 2002, 16 (12) :1472-1487
[4]   Defining the role of mTOR in cancer [J].
Guertin, David A. ;
Sabatini, David M. .
CANCER CELL, 2007, 12 (01) :9-22
[5]   A role for autophagy in the extension of lifespan by dietary restriction in C-elegans [J].
Hansen, Malene ;
Chandra, Abha ;
Mitic, Laura L. ;
Onken, Brian ;
Driscoll, Monica ;
Kenyon, Cynthia .
PLOS GENETICS, 2008, 4 (02)
[6]   Upstream and downstream of mTOR [J].
Hay, N ;
Sonenberg, N .
GENES & DEVELOPMENT, 2004, 18 (16) :1926-1945
[7]  
Hirose E, 1998, J CELL SCI, V111, P11
[8]   Genetic Dissection of the Oncogenic mTOR Pathway Reveals Druggable Addiction to Translational Control via 4EBP-eIF4E [J].
Hsieh, Andrew C. ;
Costa, Maria ;
Zollo, Ornella ;
Davis, Cole ;
Feldman, Morris E. ;
Testa, Joseph R. ;
Meyuhas, Oded ;
Shokat, Kevan M. ;
Ruggero, Davide .
CANCER CELL, 2010, 17 (03) :249-261
[9]   Cullin3-Based Polyubiquitination and p62-Dependent Aggregation of Caspase-8 Mediate Extrinsic Apoptosis Signaling [J].
Jin, Zhaoyu ;
Li, Yun ;
Pitti, Robert ;
Lawrence, David ;
Pham, Victoria C. ;
Lill, Jennie R. ;
Ashkenazi, Avi .
CELL, 2009, 137 (04) :721-735
[10]   MTOR interacts with Raptor to form a nutrient-sensitive complex that signals to the cell growth machinery [J].
Kim, DH ;
Sarbassov, DD ;
Ali, SM ;
King, JE ;
Latek, RR ;
Erdjument-Bromage, H ;
Tempst, P ;
Sabatini, DM .
CELL, 2002, 110 (02) :163-175